Bladder Neoplasm: Clinical Trials

2 trials for Bladder Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Terminated 2

Follow Bladder Neoplasm: new trials by email Literature Review of Bladder Neoplasm trials Research Report on Bladder Neoplasm

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mitomycin C Intravesical Chemotherapy in Conjunction With Synergo® Radiofrequency-Induced Hyperthermia for Treatment of Carcinoma in Situ Non-Muscle Invasive Bladder Cancer Patients Unresponsive to Bacillus Calmette-Guérin, With or Without Papillary Tumors.
Synergo® RITE + MMC - Bladder Cancer, Bladder Neoplasm
Phase 3TerminatedMedical Enterprises Ltd.52019-04-042020-04-15
Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
EN3348, Mitomycin C - Bladder Neoplasm, Neoplasm Recurrence, Local
Phase 3TerminatedBioniche Life Sciences Inc.842010-11-012017-08-24

Narrower conditions

Urinary Bladder Neoplasms (2)  ·  Carcinoma in Situ (1)  ·  Carcinoma, Transitional Cell (1)  ·  Disease (1)  ·  Mycobacterium Infections (1)  ·  Neoplasm Recurrence, Local (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Urinary Bladder Diseases (1)  ·  Urogenital Neoplasms (1)  ·  Urologic Diseases (1)  ·  Urologic Neoplasms (1)

Broader conditions

Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Male Urogenital Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Urogenital Diseases (2)  ·  Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Carcinoma (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)

Interventions

Mitomycin (2)

Sponsors

Bioniche Life Sciences Inc. (1)  ·  Medical Enterprises Ltd. (1)

Countries

United States (2)  ·  Canada (1)  ·  Germany (1)  ·  Netherlands (1)  ·  Poland (1)  ·  United Kingdom (1)

Top investigators

Michael A O'Donnell, MD (1)